Musk vs. Altman: What Is This Really About?
In a landmark trial between Elon Musk and OpenAI’s Sam Altman, the origins of OpenAI are being examined. The Times’s technology reporter Cade Metz explains what’s behind it all.
In a landmark trial between Elon Musk and OpenAI’s Sam Altman, the origins of OpenAI are being examined. The Times’s technology reporter Cade Metz explains what’s behind it all.
A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
Blackstone and Goldman Sachs are among the investors in the new firm, which will help integrate Anthropic’s A.I. model Claude into their systems.
The legal team implied in a federal trial that Greg Brockman, OpenAI’s president and co-founder, was driven by greed rather than building safe A.I.
In a series of landmark trials, plaintiffs are alleging that Meta, TikTok, Snap and YouTube caused personal injury through addictive products. Our technology reporter Cecilia Kang describes what’s at stake for tech giants and social media users.
Starting this week, a series of trials will test a new legal strategy claiming that Meta, TikTok, Snap and YouTube caused personal injury through addictive products.
The military tested a new approach in Venezuela and during strikes on Iranian nuclear facilities.
This month, resolve to revive or relinquish those old music players and point-and-shoot cameras — and retrieve any files trapped on the devices.
Founded by researchers from Anthropic, Google and xAI, the new company, Humans&, is already valued at $4.48 billion.